FREE Case Review (866) 588-0600

Kansas Tylenol Autism Lawsuit: Get the Right Attorney

Award Logos
Awards & recognition
C.L. Mike Schmidt Published by C.L. Mike Schmidt

The unfolding Tylenol autism lawsuit in Kansas has sparked a significant debate, questioning the link between acetaminophen use during pregnancy and neurodevelopmental issues such as autism and ADHD.

Families affected by these conditions are actively pursuing legal avenues, contending that the manufacturers of Tylenol failed to provide adequate warnings about these potential risks.

In this article, we aim to dissect the scientific basis of these claims, scrutinize the legal environment in Kansas, and provide practical advice for families seeking reparation.

At Schmidt & Clark, LLP, we are vigilantly monitoring these developments and are prepared to guide families through the complexities of seeking compensation in such cases, offering our expertise in both legal and medical realms.

Understanding Tylenol, Autism, and ADHD

Tylenol, commonly used for relieving pain and containing acetaminophen, is associated with a heightened risk of autism and ADHD when consumed during pregnancy.

Contrary to the FDA’s assertion of Tylenol’s safety for pregnant women under directed use, studies suggest that acetaminophen exposure prenatally could escalate the risk of neurodevelopmental disorders like autism and ADHD [1][2].

A consensus statement published in Nature Reviews Endocrinology advises caution when considering acetaminophen use during pregnancy, recommending the lowest effective dose for the shortest duration.

Parents of children born with autism after taking acetaminophen during pregnancy have taken legal action. They have pursued product liability lawsuits against drug manufacturers and retailers. These Tylenol autism lawsuits allege that the companies failed to provide appropriate warnings to parents about the potential risks, despite being aware of them.

So far, at least 20 lawsuits have been filed in six states, some of which also allege a link between Tylenol and attention deficit hyperactivity disorder (ADHD). In light of these Tylenol autism claims, parents need to be aware of the possible risks associated with the use of this medication during pregnancy [3].

The continuous Tylenol autism lawsuits have been merged into a multidistrict litigation (MDL). With Tylenol autism lawsuits filed, it is expected that thousands of new cases will be lodged in the forthcoming years.

Should the motions to exclude plaintiffs’ experts be denied, a major global settlement may be reached in the upcoming year for acetaminophen autism lawsuits.

Kansas Tylenol Autism Lawsuit

In federal court, several families are reviewing Tylenol autism lawsuits, focusing on the potential acetaminophen autism link. These cases allege that the use of generic acetaminophen, such as Tylenol, by pregnant women might have led to their children developing autism spectrum disorder or attention deficit hyperactivity disorder (ADHD).

They argue that companies like Walmart and CVS failed to alert consumers about the increased risk of pervasive developmental disorders associated with acetaminophen use during pregnancy.

These ADHD lawsuits seek financial redress for the costs of treatment, therapy, and other damages related to the diagnoses. The compensation range in successful Tylenol autism cases might reach between $500,000 and $2,000,000. Filing a claim is seen as a step towards obtaining justice and covering the expenses linked to these conditions.

Schmidt & Clark offers case evaluation forms and free consultations for families considering legal action due to concerns about the acetaminophen autism connection. This follows a recent motion to dismiss the ongoing litigation over the alleged Tylenol autism link, highlighting the ongoing debate over the scientific evidence.

Scientific Groundwork: Linking Tylenol to Neurodevelopmental Issues

Several studies have affirmed a correlation between exposure to acetaminophen during pregnancy and a heightened risk of autism spectrum disorder (ASD) and ADHD.

For instance, a study published in JAMA Psychiatry demonstrated that umbilical cord biomarkers of fetal exposure to acetaminophen were linked to an increased risk of childhood ADHD and autism spectrum disorder ASD in a dose-dependent manner. This research provides a scientific basis for the lawsuits filed by affected families.

Another study published in the European Journal of Epidemiology found that unborn children with prenatal exposure to acetaminophen were 19% more likely to exhibit signs of autism and 21% more likely to present indications of ADHD compared to those not exposed.

These findings further support the notion that prenatal acetaminophen exposure may be linked to neurodevelopmental disorders. Despite the scientific proof backing the lawsuit claims, one must bear in mind that a correlation does not necessarily mean causation.

While the studies suggest a potential association between acetaminophen exposure and neurodevelopmental disorders, more research is needed to fully understand the relationship and its implications for affected families who might consider using generic acetaminophen.

The legal procedure in Kansas entails amalgamating individual cases into a class action or MDL, with plaintiffs pursuing compensation for medical costs and other damages.

A class action lawsuit is a legal proceeding wherein a group of individuals with similar grievances against a defendant unite to launch a lawsuit as a single plaintiff, thus enabling a more efficient and cost-effective resolution of shared legal matters.

Multidistrict Litigation (MDL) is a procedure utilized in the federal court system to consolidate multiple civil cases that share similar elements. In Kansas, MDL cases are transferred to one federal judge to facilitate the legal process and increase efficiency. This expedites the resolution of complex cases with multiple plaintiffs.

Filing a motion to consolidate with the court is typically the procedure utilized to consolidate individual lawsuits into a class action or MDL in Kansas. The court will then evaluate the motion and decide whether consolidation is suitable based on factors such as common legal or factual issues among individual lawsuits.

If the court grants the motion, the individual lawsuits will be consolidated into a single class action or transferred to a multidistrict litigation (MDL) for more effective management.

Client Guidance: Filing a Lawsuit in Kansas

To lodge a Tylenol autism lawsuit in Kansas, impacted families should follow these steps:

  1. Seek advice from seasoned attorneys who can guide them through the intricate legal procedure and ascertain their eligibility for compensation.
  2. Gather evidence to support their case.
  3. Assess damages caused by Tylenol and its potential link to autism.
  4. File the lawsuit with the appropriate court.
  5. Participate in legal proceedings, including hearings and negotiations.

By following these steps, families can navigate the process of filing a Tylenol autism lawsuit in Kansas.

Legal documents such as health record authorization forms and relevant medical information may be necessary to file a Tylenol autism lawsuit in Kansas. An attorney can provide the following services:

  • Legal advice
  • Assess the case
  • Collect evidence
  • Submit the appropriate documents
  • Serve as a representative in court
  • Guide the legal process
  • Mediate settlements
  • Pursue compensation for losses

The legal costs linked to filing a Tylenol autism lawsuit in Kansas may differ based on the law firm you choose. Some lawyers work on a contingency fee basis, meaning they are only remunerated if your case is successful. It is recommended to consult with a lawyer to obtain specific information regarding the legal fees in your case.

Statute of Limitations

The timeframe for filing a Tylenol autism lawsuit in Kansas may differ, thus impacted families need to act quickly and obtain legal advice. In Kansas, the statute of limitations for product liability lawsuits typically ranges from one to eight years, with a general limitation of two years.

The discovery rule applies to Tylenol autism lawsuits in Kansas, implying that the statute of limitations commences when the plaintiff discovers or should have discovered their injury.

This rule can influence the statute of limitations by permitting plaintiffs to file a lawsuit within a certain period after recognizing their injury, even if the standard statute of limitations has elapsed.

No changes have been made to the statute of limitations for product liability lawsuits in Kansas law. The limitation of ten years, as outlined in K.S.A. 60-513, remains in effect. Affected families need to consult with an attorney to ensure they file their lawsuit within the appropriate time frame.

Related Articles:

See all related dangerous drugs lawsuits our lawyers covered so far.


  1. NIH-funded study suggests acetaminophen exposure in pregnancy linked to higher risk of ADHD, autism
  2. Can Acetaminophen Increase the Risk of Autism or ADHD?
  3. Taking Tylenol during pregnancy associated with elevated risks for autism, ADHD